United States: The number of male cancer cases globally is likely to rise from 10.3 million in 2022 and by 2050 to 19 million – in other words, it will increase by 84 percent, according to Australian health specialists.
More about the news
Worse still, the mortality rates are projected to increase; cancer-related deaths in men will be 93 percent higher than what is recorded today, from 5.4 million in 2022 to 10.5 million in 2050.
The researchers dissected 30 cancer kinds and a vast population of over 185 countries and regions to forecast the cancer rates among males in 2050.
Their research was reported Monday in CANCER, a peer-reviewed scientific journal of the American Cancer Society.
According to the study authors, more incidences of cancer and cancer deaths occur in men because more men smoke and consumption of alcohol as compared with women, as the New York Post reported.
Men are also at a higher risk of being in contact with work-related carcinogens and more likely not to undertake cancer screening.
Older adults have a worse survival rate
Young men have more favorable survival rates than seniors, which the authors of the work explained by poor tolerance of treatment, the time of the diagnosis, and the inability to pay for medical services in senior men 65 and above.
In older men, the cancer incidence rate is expected to increase from 6 million in 2022 to 13.1 million in 2050, and the death rate would be 3.4 million to 7. 7 million over the same period.
Other than age, the researchers also pointed out that cancer outcome inequalities were increasing concerning countries’ economic status.
Lung cancer is regarded as the leading cause of cancer and cancer deaths in 2022, and it is predicted that it will retain this position in 2050; the number of instances and deaths is estimated to rise more than 87 percent in 2022, as the New York Post reported.
More about the finding
It should also be noted that there are over 1.25 billion tobacco users globally in current year data, according to WHO, while many people are quitting this vice.
Prostate and colorectal cancer also seem to be at the forefront of the epidemic of cancer diseases. It is expected that the death rate from prostate cancer will rise by one hundred and thirty-six percent between 2022 and 2050, a situation that researchers attribute to the fact that men are living longer, hence giving the disease enough time to manifest itself.
It is anticipated that mortalities from prostate cancer will rise by 136% between 2022 and 2050, a situation that researchers attribute to the fact that men are living longer, hence giving the disease enough time to manifest itself.
However, the incidence of mesothelioma is forecasted to grow at the greatest rate among the cancer types, with 105 percent growth from the 2022 level.
It arises from thin tissue found in the lungs and other organs—a form of cancer that is rare but highly malignant. Thus, the occurrence of mesothelioma has been attributed to populations getting older and exposure to asbestos.
Skin cancer should also kill more people in 2050; bladder cancer should be diagnosed more and should kill more.